Su Zhen
Direktor/Vorstandsmitglied bei KARYOPHARM THERAPEUTICS INC.
Ursprung des Netzwerks ersten Grades von Su Zhen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
41
| Public Company | Pharmaceuticals: Major | 41 |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 14 | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA.
11
| Holding Company | Biotechnology | 11 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Su Zhen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Compliance Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing General Counsel Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Sales & Marketing Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IPSEN | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GALAPAGOS NV | Biotechnology | Director/Board Member Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BEIERSDORF | Household/Personal Care | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
| MIRATI THERAPEUTICS | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Toronto | College/University | Masters Business Admin Doctorate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Doctorate Degree | |
| Universität zu Köln | College/University | Graduate Degree Doctorate Degree | |
| Technische Universität Darmstadt | College/University | Masters Business Admin Graduate Degree | |
| Ashridge Business School | College/University | Graduate Degree Masters Business Admin | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Founder Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Industriegewerkschaft Bergbau Chemie Energie
 Industriegewerkschaft Bergbau Chemie Energie Miscellaneous Commercial ServicesCommercial Services Industriegewerkschaft Bergbau Chemie Energie operates as a trade union. The private company is based in Hannover, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Medical Specialties | Chairman Corporate Officer/Principal | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRAEBURN INC. | Miscellaneous Commercial Services | Chairman Director/Board Member Private Equity Investor | |
Aulos Bioscience, Inc.
 Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Replicate Bioscience, Inc.
 Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Nereid Therapeutics, Inc.
 Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member | |
Ascidian Therapeutics, Inc.
 Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Galvanize Therapeutics, Inc.
 Galvanize Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Galvanize Therapeutics, Inc. operates as a biotechnology firm. The company was founded in 2020 and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman Director/Board Member | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| RAYZEBIO, INC. | Biotechnology | Founder Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Merck Healthcare | Chief Operating Officer Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 33 |
| Deutschland | 9 |
| Vereinigtes Königreich | 5 |
| Frankreich | 3 |
| Belgien | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Consumer Non-Durables | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 338 |
| Corporate Officer/Principal | 230 |
| Chief Executive Officer | 131 |
| Independent Dir/Board Member | 98 |
| Undergraduate Degree | 65 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Helene von Roeder | 85 |
| Seth Harrison | 43 |
| Elaine Jones | 37 |
| Deepa Pakianathan | 32 |
| Chen Schor | 23 |
| Belén Garijo López | 22 |
| Simon Sturge | 20 |
| Peter Honig | 20 |
| Aaron Kantoff | 19 |
| Michael Kleinemeier | 19 |
| Barry Greene | 18 |
| Elizabeth Jobes | 18 |
| Halley Gilbert | 17 |
| Garen Bohlin | 17 |
| Gregor Schulz | 16 |
